Ampersand is a middle market private equity firm focused on investments in two core sectors: Healthcare and Industrial.
Business Model:
Revenue: $15M
Employees: 11-50
Address: 55 William Street
City: Wellesley Hills
State: MA
Zip: 02481
Country: US
[Ampersand](http://www.ampersandventures.com/) is a middle market private equity firm focused on investments in two core sectors: Healthcare and Industrial.
Contact Phone:
+17812390700
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
10/2019 | Arranta Bio | Series B | 82M |
1/2018 | Bioventus | Venture Round | - |
1/2000 | Silicon Wave | Series C | 35M |
1/2018 | Sanova Dermatology | Private Equity Round | - |
12/2004 | ProGene Biomedical | Venture Round | 5M |
1/2008 | Signature Genomic Laboratories | Venture Round | - |
1/2014 | Bako Diagnostics | Private Equity Round | - |
2/2002 | Endeca | Series C | 0 |
10/2019 | vivitide | Venture Round | - |
1/2013 | Agilux Laboratories | Seed Round | - |
1/2008 | FirstRain | Venture Round | 0 |
6/2002 | Viadux | Venture Round | 0 |
2/2004 | LightPointe | Venture Round | 17M |
6/2003 | Silicon Wave | Series E | 10.3M |
1/2015 | GENEWIZ | Venture Round | - |
5/2004 | Panacos Pharmaceuticals | Post-IPO Equity | 0 |
6/2001 | Blackstone Technology Group | Series B | 12.6M |
1/2021 | Avista Pharma | Private Equity Round | - |
4/2004 | Proficiency | Series D | 12M |
11/2006 | Magellan Diagnostics | Private Equity Round | 0 |
6/2007 | Cequent Pharmaceuticals | Series A | 9M |
6/2022 | AnaBios | Private Equity Round | 0 |
5/2019 | Genome Diagnostics (GenDx) | Private Equity Round | - |
6/2022 | Vernal Biosciences | Series A | 0 |
6/2022 | Vernal Biosciences | Venture Round | 0 |
6/2022 | Sterling Medical Devices | Private Equity Round | - |
1/2002 | Ensemble Communications | Venture Round | 0 |
9/2000 | LightPointe | Series A | 12M |
7/1999 | Silicon Wave | Series B | 14.3M |
11/2007 | RadPharm | Series B | 10M |
5/2012 | Bioventus | Venture Round | 0 |
8/2000 | Silicon Wave | Series D | 0 |
6/2023 | Vernal Biosciences | Series A | 0 |
6/2023 | NanoImaging Services | Private Equity Round | - |
3/2022 | BioEcho Life Sciences | Private Equity Round | - |
5/2005 | Assay Designs | Series A | 5M |
4/2006 | FirstRain | Venture Round | 18.7M |
10/2019 | New England Peptide | Private Equity Round | - |
1/2017 | Canopy Biosciences | Seed Round | 2M |
1/2018 | Adaptas Solutions | Private Equity Round | - |
4/2022 | Syft Technologies | Private Equity Round | - |
3/2021 | Magritek Ltd | Private Equity Round | - |
1/2019 | Elite One Source Nutritional Services | Private Equity Round | - |
3/2018 | MedPharm | Venture Round | - |
8/2007 | Chantest | Venture Round | - |
3/2021 | Arranta Bio | Series B | - |
10/2001 | Endeca | Series B | 15M |
2/2017 | Corpus Medical | Venture Round | - |
1/2018 | Detector Technology | Private Equity Round | - |
3/2018 | Nexcelom Bioscience | Private Equity Round | - |
6/2019 | N2 Biomedical LLC | Venture Round | - |
3/2011 | Blue Sky Biotech | Private Equity Round | - |
1/1999 | Silicon Wave | Series A | 9M |
1/2005 | Medifacts International | Series A | 0 |
3/2010 | FirstRain | Venture Round | 0 |
1/2021 | Brammer Bio | Private Equity Round | - |
12/2017 | LakePharma | Private Equity Round | 30M |
1/2014 | NutraMed | Debt Financing | 12.5M |
1/2011 | Ortho Organizers | Private Equity Round | - |
7/2001 | LightPointe | Series B | 33M |
7/2003 | FirstRain | Series B | 8.3M |
4/2019 | Canopy Biosciences | Venture Round | - |
4/2011 | Nitinol Devices &a; Components | Venture Round | 20M |
12/2003 | Silicon Wave | Series F | 4M |
1/2013 | CRI Lifetree | Private Equity Round | - |
1/2002 | Cyclis Pharmaceuticals | Series A | 5M |
1/2015 | Azurity Pharmaceuticals | Private Equity Round | - |
1/2016 | CoreLab Partners | Private Equity Round | - |
6/2004 | Endeca | Series D | 15M |
6/2023 | Vernal Biosciences | Series A | 0 |
6/2023 | NanoImaging Services | Private Equity Round | - |
6/2022 | Sterling Medical Devices | Private Equity Round | - |
6/2022 | AnaBios | Private Equity Round | 0 |
6/2022 | Vernal Biosciences | Series A | 0 |
4/2022 | Syft Technologies | Private Equity Round | - |
3/2022 | BioEcho Life Sciences | Private Equity Round | - |
3/2021 | Magritek Ltd | Private Equity Round | - |
3/2021 | Arranta Bio | Series B | - |
1/2021 | Avista Pharma | Private Equity Round | - |
Name | Price |
---|
Name | Size | Announced Date |
---|